PERSPECTA

News from every angle

← Back to headlines

Analysis Explains Revolution Medicines' $29 Billion Valuation Despite No Revenue

An article provides an explanation for Revolution Medicines' substantial $29 billion market capitalization, arguing that its valuation may not be as unreasonable as it appears despite generating no revenue.

27 Apr, 15:20 — 27 Apr, 15:20
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual126d ago

Revolution Medicines Has a Market Cap of $29 Billion and Generates No Revenue. Here's Why Its Valuation May Not Be as Ridiculous as It Seems

Read full article →

Related Stories

Shein Shares Plunge 10% in Hong Kong Stock Exchange Debut

20m ago

Japan’s Benchmark Bond Yield Hits 3% for First Time in Three Decades

27m ago

Tim Cook Steps Down as Apple CEO as John Ternus Takes Over

41m ago

France moves to impose fines on Chinese fast-fashion giants Shein and Temu

44m ago